Excitatory/inhibitory balance in epilepsies and neurodevelopmental disorders: Depolarizing γ‐aminobutyric acid as a common mechanism
EJH van van Hugte, D Schubert, N Nadif Kasri - Epilepsia, 2023 - Wiley Online Library
Epilepsy is one of the most common neurological disorders. Although many factors
contribute to epileptogenesis, seizure generation is mostly linked to hyperexcitability due to …
contribute to epileptogenesis, seizure generation is mostly linked to hyperexcitability due to …
A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders
CJ McArdle, AA Arnone, CF Heaney… - Frontiers in …, 2024 - frontiersin.org
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central
nervous system. In the mature brain, inhibitory GABAergic signaling is critical in maintaining …
nervous system. In the mature brain, inhibitory GABAergic signaling is critical in maintaining …
Assessment of the excitation–inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamics
R Kat, K Linkenkaer-Hansen, MA Koopmans… - Cerebral …, 2024 - academic.oup.com
In vitro and ex vivo studies have shown consistent indications of hyperexcitability in the
Fragile X Messenger Ribonucleoprotein 1 (Fmr1) knockout mouse model of autism spectrum …
Fragile X Messenger Ribonucleoprotein 1 (Fmr1) knockout mouse model of autism spectrum …
Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm
D Samanta - Epilepsy & Behavior, 2024 - Elsevier
Tuberous sclerosis Complex (TSC) is a genetic disorder characterized by multisystem
involvement, with epilepsy affecting 80–90% of patients, often beginning in infancy. Early-life …
involvement, with epilepsy affecting 80–90% of patients, often beginning in infancy. Early-life …
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3, 4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients …
CA Erickson, L Perez-Cano, EV Pedapati, E Painbeni… - Biomedicines, 2024 - mdpi.com
This study aimed to evaluate the safety and tolerability of STP1, a combination of ibudilast
and bumetanide, tailored for the treatment of a clinically and biologically defined subgroup …
and bumetanide, tailored for the treatment of a clinically and biologically defined subgroup …
Functional excitation-inhibition ratio indicates near-critical oscillations across frequencies
The concept of excitation/inhibition (E/I) balance plays an important role in understanding
brain function in health and disease. We recently introduced an algorithm to determine a …
brain function in health and disease. We recently introduced an algorithm to determine a …
Qualitative EEG abnormalities signal a shift towards inhibition-dominated brain networks. Results from the EU-AIMS LEAP studies
Qualitative EEG abnormalities are common in Autism Spectrum Disorder (ASD) and
hypothesized to reflect disrupted excitation/inhibition balance. To test this, we recently …
hypothesized to reflect disrupted excitation/inhibition balance. To test this, we recently …
[PDF][PDF] Clinically relevant associations between qualitative EEG abnormalities and excitation-inhibition ratio in the Longitudinal European Autism Project
EL Juarez-Martinez - VU Research Portal, 2024 - research.vu.nl
ABSTRACT A continuum between EEG abnormalities and excitation/inhibition imbalances
has been suggested in seizure-free patients with autism spectrum disorder (ASD). It is …
has been suggested in seizure-free patients with autism spectrum disorder (ASD). It is …
Regulation of critical brain dynamics and its functional implications
AE Avramiea - 2023 - research.vu.nl
Evidence of criticality at various levels of neuronal organization has accumulated over the
past 2 decades. However, little is known of how criticality affects brain function, whether the …
past 2 decades. However, little is known of how criticality affects brain function, whether the …
Safety, Tolerability and EEG-Based Target Engagement of STP1 (PDE3, 4 Inhibitor and NKCC1 Antagonist), in a Randomized Clinical Trial in a Subgroup of Patients …
B Gomez-Mancilla, C Erickson, EV Pedapati… - 2024 - preprints.org
This study aimed to evaluate the safety and tolerability of STP1, a combination of ibudilast
and bumetanide, tailored for the treatment of a specific subgroup of patients with Autism …
and bumetanide, tailored for the treatment of a specific subgroup of patients with Autism …